Funds and ETFs Merck KGaA

Equities

MRK

DE0006599905

Pharmaceuticals

Market Closed - Xetra 11:35:20 2024-06-11 am EDT After market 01:02:49 pm
171.8 EUR -0.06% Intraday chart for Merck KGaA 171.8 -0.01%

ETFs positioned on Merck KGaA

Name Weight AuM 1st Jan change Investor Rating
0.05% 7 M€ +0.11% -
0.05% 786 M€ -.--%
0.05% 23 M€ -.--% -
0.05% 284 M€ -.--%
0.05% 288 M€ +22.45%
0.05% 206 M€ -.--%
0.04% 1,166 M€ +0.26% -
0.04% 607 M€ +0.05% -
0.04% 414 M€ +10.13% -
0.04% 0 M€ 0.00% -
0.03% 36 M€ +9.99% -
0.02% 324 M€ +6.77% -
0.02% 40 M€ +6.85% -
0.02% 104 M€ +4.15% -
0.02% 17 M€ +3.47% -
0.01% 32 M€ +4.06% -
0.01% 248 M€ +10.67% -
0.01% 55 M€ +0.94% -
0.01% 8 M€ +0.90% -
0.00% 145 M€ -1.80% -
0.00% 1 M€ 0.00% -
0.00% 28 M€ -1.33% -
0.00% 25 M€ -2.35% -
298.38% 13 M€ +7.12% -
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (44.2%); - pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
171.9 EUR
Average target price
186.1 EUR
Spread / Average Target
+8.24%
Consensus
  1. Stock Market
  2. Equities
  3. MRK Stock
  4. Funds and ETFs Merck KGaA